BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1456 related articles for article (PubMed ID: 24522162)

  • 1. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome.
    Zhang S; Wu Z; Li P; Bai Y; Zhang F; Li Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2059. PubMed ID: 26579816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
    De Craemer AS; Musial J; Devreese KM
    J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies.
    Forastiero R; Papalardo E; Watkins M; Nguyen H; Quirbach C; Jaskal K; Kast M; Teodorescu M; Lakos G; Binder W; Shums Z; Nelson V; Norman G; Puig J; Cox A; Vandam W; Hardy J; Pierangeli S
    Clin Chim Acta; 2014 Jan; 428():99-105. PubMed ID: 24252665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():297-314. PubMed ID: 37204719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome.
    Devreese KMJ
    Int J Lab Hematol; 2024 May; 46 Suppl 1():34-42. PubMed ID: 38584293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.